Origin & tradition
Not traditional as an isolate: sulforaphane was identified in broccoli in 1992 and has since become the most-studied NRF2 activator.
Western tradition · Phytochemical
The most potent known NRF2 activator, from broccoli, with human trials in cancer chemoprevention and neuroprotection.
↑ iHerb link is an affiliate link — we may earn a commission at no cost to you.
Not traditional as an isolate: sulforaphane was identified in broccoli in 1992 and has since become the most-studied NRF2 activator.
Key active: Sulforaphane (isothiocyanate from broccoli/broccoli sprout extract).
Sulforaphane activates the NRF2-KEAP1 pathway, upregulating antioxidant response elements (HO-1, NQO1, GCLC). Human trials cover prostate cancer chemoprevention, autism (ABA-scale improvement), and schizophrenia. Preclinical evidence extends to senescence, neuroinflammation, and autophagy.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| NRF2 pathway / antioxidant enzyme induction | Increases | Strong | A |
| Inflammation (NF-κB) | Decreases | Moderate | B |
| Insulin sensitivity / blood glucose | Increases | Moderate | B |
| Cancer prevention markers (Phase 2 enzymes) | Increases | Moderate | B |
| Autism spectrum symptoms | Decreases | Moderate | C |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
Broccoli sprouts (3-day-old) contain 20–50× more glucoraphanin than mature broccoli. Myrosinase enzyme (also in sprouts, or added as mustard powder) is required to convert glucoraphanin to sulforaphane. Cooking inactivates myrosinase — eat sprouts raw.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Strong preclinical + human RCTs in cancer and neuro; aging trials ongoing
Sulforaphane activates the NRF2-KEAP1 pathway, upregulating antioxidant response elements (HO-1, NQO1, GCLC). Human trials cover prostate cancer chemoprevention, autism (ABA-scale improvement), and schizophrenia. Preclinical evidence extends to senescence, neuroinflammation, and autophagy.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-12. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Compare the evidence
The mitochondrial electron carrier that declines with age and statin use — with cardiovascular trial support.
A mitochondrial cofactor active in both fat and water — the only antioxidant that regenerates glutathione, vitamin C, and vitamin E simultaneously.
A gut-derived metabolite that triggers mitophagy — with human trials on muscle and mitochondrial function.
The dark chocolate flavonoid linked to myostatin inhibition, cardiovascular protection, and mitochondrial biogenesis in human trials.
Compare the evidence
Suppliers
Tell us what you need and we will source suppliers for you.